Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion:

Vincent Roule,Thibaut Heudel,Adrien Lemaitre,Mathieu Bignon,Pierre Ardouin,Rémi Sabatier,Katrien Blanchart,Farzin Beygui

Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion:

2019

Vincent Roule
Thibaut Heudel
Adrien Lemaitre
Mathieu Bignon
Pierre Ardouin
Rémi Sabatier
Katrien Blanchart
Farzin Beygui

Background:The evidence of a clinical benefit of P2Y12 inhibitor pre-treatment in primary percutaneous coronary intervention (PCI) and the relation between the level of platelet inhibition and myoc...

Keywords:

Cardiology
Platelet
Medicine
Conventional PCI
P2Y12
Myocardial reperfusion
Internal medicine
Percutaneous coronary intervention
Ticagrelor
platelet reactivity
pre treatment
platelet inhibition

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations